Add like
Add dislike
Add to saved papers

A potential biomarker for colorectal cancer: long non-coding RNA RP1-13P20.6.

Long non-coding RNAs (lncRNAs) occupy the majority of the human genome. Their dysregulation is usually related with the procession of diseases, including tumors. Abnormally expressed lncRNAs have been found in colorectal cancer (CRC), but are not fully understood. In the current study, we determined the expression level of a novel lncRNA-RP1-13P20.6 in 99 pairs of CRC tissues compared to their matched normal adjacent tissues, using real time polymerase chain reaction. We further assessed the correlation between their expression levels and their clinicopathological parameters, and determined the potential of RP1-13P20.6 as a biomarker for CRC. The expression of lncRNA-RP1-13P20.6 in CRC tissues and cell lines decreased significantly with an area under the curve (AUC) of 0.755 (p < 0.001). However, there was no significant difference between the expression levels of lncRNA-RP1-13P20.6 and the clinicopathological characteristics. The abnormal expression level and AUC values suggest that lncRNA-RP1-13P20.6 is a potential biomarker for CRC.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app